Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets
04:06pm, Thursday, 26'th Feb 2026
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading lower Thursday afternoon after the lupus-focused drugmaker posted fourth quarter earnings and raised expectations for continued growth in
Aurinia Pharmaceuticals Inc. (AUPH) Q4 2025 Earnings Call Transcript
03:28pm, Thursday, 26'th Feb 2026
Aurinia Pharmaceuticals Inc. (AUPH) Q4 2025 Earnings Call Transcript
Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates
09:16am, Thursday, 26'th Feb 2026
Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.09 per share a year ago.
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and twelve months ended December 31, 2025 and provided
ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that it will report financial results for the three and twelve months ended December 31
This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base
02:01pm, Friday, 06'th Feb 2026
This pharma stock projected to post stout earnings growth is forming a bullish chart pattern despite the stock market carnage.
Aurinia Pharmaceuticals (NASDAQ:AUPH) and Merck KGaA (OTCMKTS:MKKGY) Head-To-Head Analysis
01:24am, Sunday, 01'st Feb 2026
Merck KGaA (OTCMKTS:MKKGY - Get Free Report) and Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies
Aurinia Pharmaceuticals (NASDAQ:AUPH) Share Price Passes Above 50-Day Moving Average – Here’s Why
03:52am, Saturday, 10'th Jan 2026
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH - Get Free Report) (TSE: AUP) shares passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $15.56 and trad
Is Aurinia Pharmaceuticals (AUPH) Outperforming Other Medical Stocks This Year?
10:41am, Friday, 26'th Dec 2025
Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?
10:41am, Wednesday, 10'th Dec 2025
Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now?
01:01pm, Friday, 05'th Dec 2025
Does Aurinia Pharmaceuticals (AUPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake?
04:21pm, Tuesday, 02'nd Dec 2025
San Diego-based Tang Capital Management increased its position in AUPH by 1.3 million shares in the third quarter. Following the transaction, Tang reported holding more than 11.3 million AUPH shares v
Is Aurinia Pharmaceuticals (AUPH) Stock Outpacing Its Medical Peers This Year?
10:41am, Monday, 24'th Nov 2025
Here is how Aurinia Pharmaceuticals (AUPH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison
02:38am, Sunday, 23'rd Nov 2025
Aurinia Pharmaceuticals (NASDAQ: AUPH - Get Free Report) and PMV Pharmaceuticals (NASDAQ: PMVP - Get Free Report) are both medical companies, but which is the better business? We will contrast the two
Campbell & CO Investment Adviser LLC Sells 4,307 Shares of Aurinia Pharmaceuticals Inc $AUPH
04:42am, Monday, 17'th Nov 2025
Campbell and CO Investment Adviser LLC trimmed its holdings in Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) (TSE: AUP) by 9.8% during the second quarter, according to its most recent disclosure with the
